| Year |
Citation |
Score |
| 2024 |
Iadarola MJ, Sapio MR, Loydpierson AJ, Mervis CB, Fehrenbacher JC, Vasko MR, Maric D, Eisenberg DP, Nash TA, Kippenhan JS, Garvey MH, Mannes AJ, Gregory MD, Berman KF. Syntaxin1A overexpression and pain insensitivity in individuals with 7q11.23 duplication syndrome. Jci Insight. PMID 38261410 DOI: 10.1172/jci.insight.176147 |
0.564 |
|
| 2022 |
Behrouzi A, Xia H, Thompson EL, Kelley MR, Fehrenbacher JC. Oxidative DNA Damage and Cisplatin Neurotoxicity Is Exacerbated by Inhibition of OGG1 Glycosylase Activity and APE1 Endonuclease Activity in Sensory Neurons. International Journal of Molecular Sciences. 23. PMID 35163831 DOI: 10.3390/ijms23031909 |
0.363 |
|
| 2022 |
Cunningham GM, Shen F, Wu X, Cantor EL, Gardner L, Philips S, Jiang G, Bales CL, Tan Z, Liu Y, Wan J, Fehrenbacher JC, Schneider BP. The impact of SBF2 on taxane-induced peripheral neuropathy. Plos Genetics. 18: e1009968. PMID 34986146 DOI: 10.1371/journal.pgen.1009968 |
0.325 |
|
| 2021 |
McCarson KE, Fehrenbacher JC. Models of Inflammation: Carrageenan- or Complete Freund's Adjuvant (CFA)-Induced Edema and Hypersensitivity in the Rat. Current Protocols. 1: e202. PMID 34314105 DOI: 10.1002/cpz1.202 |
0.343 |
|
| 2020 |
Cunningham G, Cantor E, Wu X, Shen F, Jiang G, Philips S, Bales C, Xiao Y, Cummins TR, Fehrenbacher JC, Schneider BP. Abstract P5-07-09: Modeling taxane-induced peripheral neuropathy ex vivo using patient-derived neurons Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-07-09 |
0.462 |
|
| 2019 |
Staff NP, Fehrenbacher JC, Caillaud M, Damaj MI, Segal RA, Rieger S. Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems. Experimental Neurology. 113121. PMID 31758983 DOI: 10.1016/J.Expneurol.2019.113121 |
0.415 |
|
| 2019 |
Sun S, Diggins NH, Gunderson ZJ, Fehrenbacher JC, White FA, Kacena MA. No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing. Bone. 115109. PMID 31715336 DOI: 10.1016/J.Bone.2019.115109 |
0.357 |
|
| 2018 |
Kelley MR, Messmann RA, Fehrenbacher J. Novel first-in-class small molecule targeting APE1/Ref-1 to prevent and treat chemotherapy-induced peripheral neuropathy (CIPN). Journal of Clinical Oncology. 36: 229-229. DOI: 10.1200/Jco.2018.36.34_Suppl.229 |
0.394 |
|
| 2018 |
Shah FL, Atallah N, Grimard M, Guo C, Zhang C, Fehrenbacher J, Kelley MR, Fishel M. Abstract 4802: Combination therapy in PDAC involving blockade of the APE1/Ref-1 signaling pathway: An investigation into drug synthetic lethality and anti-neuropathy therapeutic approach Cancer Research. 78: 4802-4802. DOI: 10.1158/1538-7445.Am2018-4802 |
0.357 |
|
| 2017 |
Fehrenbacher JC, Guo C, Kelley MR, Vasko MR. DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1. Neuroscience. PMID 28965839 DOI: 10.1016/J.Neuroscience.2017.09.039 |
0.671 |
|
| 2017 |
Darby LM, Meng H, Fehrenbacher JC. Paclitaxel inhibits the activity and membrane localization of PKCα and PKCβI/II to elicit a decrease in stimulated calcitonin gene-related peptide release from cultured sensory neurons. Molecular and Cellular Neurosciences. PMID 28404507 DOI: 10.1016/j.mcn.2017.04.001 |
0.539 |
|
| 2016 |
Malty RH, Hudmon A, Fehrenbacher JC, Vasko MR. Long-term exposure to PGE2 causes homologous desensitization of receptor-mediated activation of protein kinase A. Journal of Neuroinflammation. 13: 181. PMID 27400965 DOI: 10.1186/S12974-016-0645-0 |
0.663 |
|
| 2016 |
Duarte DB, Vasko MR, Fehrenbacher JC. Models of Inflammation: Carrageenan Air Pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. 72: 5.6.1-9. PMID 26995549 DOI: 10.1002/0471141755.ph0506s72 |
0.602 |
|
| 2016 |
Pittman SK, Gracias NG, Fehrenbacher JC. Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons. Experimental Neurology. PMID 26883566 DOI: 10.1016/J.Expneurol.2016.02.010 |
0.749 |
|
| 2015 |
Fehrenbacher JC. Chemotherapy-induced peripheral neuropathy. Progress in Molecular Biology and Translational Science. 131: 471-508. PMID 25744683 DOI: 10.1016/bs.pmbts.2014.12.002 |
0.361 |
|
| 2015 |
Fehrenbacher JC, Bingener J, Aho JM, Wasky PR, Locke EE, Schwesinger WH, Van Sickle KR, Hargreaves KM. Men with acute cholecystitis have higher tissue-based cytokine levels than women: A cross-sectional study Chirurgia (Turin). 28: 49-53. |
0.4 |
|
| 2014 |
Chen X, Sun W, Gianaris NG, Riley AM, Cummins TR, Fehrenbacher JC, Obukhov AG. Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel. The Journal of Biological Chemistry. 289: 9600-10. PMID 24569998 DOI: 10.1074/Jbc.M113.536862 |
0.376 |
|
| 2014 |
Pittman SK, Gracias NG, Vasko MR, Fehrenbacher JC. Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture. Experimental Neurology. 253: 146-53. PMID 24374060 DOI: 10.1016/J.Expneurol.2013.12.011 |
0.73 |
|
| 2012 |
Duarte DB, Vasko MR, Fehrenbacher JC. Models of inflammation: carrageenan air pouch. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.6. PMID 22383000 DOI: 10.1002/0471141755.ph0506s56 |
0.599 |
|
| 2012 |
Fehrenbacher JC, Vasko MR, Duarte DB. Models of inflammation: Carrageenan- or complete Freund's Adjuvant (CFA)-induced edema and hypersensitivity in the rat. Current Protocols in Pharmacology / Editorial Board, S.J. Enna (Editor-in-Chief) ... [Et Al.]. Unit5.4. PMID 22382999 DOI: 10.1002/0471141755.ph0504s56 |
0.654 |
|
| 2011 |
Brittain JM, Duarte DB, Wilson SM, Zhu W, Ballard C, Johnson PL, Liu N, Xiong W, Ripsch MS, Wang Y, Fehrenbacher JC, Fitz SD, Khanna M, Park CK, Schmutzler BS, et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⺠channel complex. Nature Medicine. 17: 822-9. PMID 21642979 DOI: 10.1038/Nm.2345 |
0.671 |
|
| 2011 |
Khanna R, Brittain J, Duarte D, Wilson S, Zhu W, Ballard C, Johnson P, Liu N, Xiong W, Ripsch M, Wang Y, Fehrenbacher J, Khanna M, Park C, Brustovetsky N, et al. Suppression of inflammatory and neuropathic pain by uncoupling collapsin response mediator protein 2 (CRMP-2) from the presynaptic calcium channel complex F1000research. 2. DOI: 10.7490/F1000Research.1089589.1 |
0.603 |
|
| 2010 |
Park KA, Fehrenbacher JC, Thompson EL, Duarte DB, Hingtgen CM, Vasko MR. Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons. Neuroscience. 171: 910-23. PMID 20870010 DOI: 10.1016/J.Neuroscience.2010.09.027 |
0.764 |
|
| 2009 |
Fehrenbacher JC, Sun XX, Locke EE, Henry MA, Hargreaves KM. Capsaicin-evoked iCGRP release from human dental pulp: a model system for the study of peripheral neuropeptide secretion in normal healthy tissue. Pain. 144: 253-61. PMID 19428185 DOI: 10.1016/j.pain.2009.03.027 |
0.617 |
|
| 2009 |
Fehrenbacher JC, Loverme J, Clarke W, Hargreaves KM, Piomelli D, Taylor BK. Rapid pain modulation with nuclear receptor ligands. Brain Research Reviews. 60: 114-24. PMID 19162071 DOI: 10.1016/J.Brainresrev.2008.12.019 |
0.619 |
|
| 2009 |
Buck L, Fehrenbacher JC, Hargreaves K, Schwesinger WH, Van Sickle K, Bingener J. M1525 Tissue Cytokines Reveal Gender Difference in Acute Cholecystitis Gastroenterology. 136: A-889. DOI: 10.1016/S0016-5085(09)64107-X |
0.488 |
|
| 2008 |
Jeske NA, Diogenes A, Ruparel NB, Fehrenbacher JC, Henry M, Akopian AN, Hargreaves KM. A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain. 138: 604-16. PMID 18381233 DOI: 10.1016/j.pain.2008.02.022 |
0.726 |
|
| 2008 |
Fehrenbacher J, Hargreaves K, Rodriguez LJ, Schwesinger WH, Sirinek K, Van Sickle K, Olivarri S, Lopez P, Bingener J. QS271. Men Exhibit Markedly Increased Tissue Level Cytokines in Acute Cholecystitis Journal of Surgical Research. 144: 374-375. DOI: 10.1016/j.jss.2007.12.521 |
0.491 |
|
| 2006 |
Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, Hargreaves KM. PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain. 125: 114-24. PMID 16781076 DOI: 10.1016/j.pain.2006.05.007 |
0.749 |
|
| 2006 |
Zhang YH, Fehrenbacher JC, Vasko MR, Nicol GD. Sphingosine-1-phosphate via activation of a G-protein-coupled receptor(s) enhances the excitability of rat sensory neurons. Journal of Neurophysiology. 96: 1042-52. PMID 16723416 DOI: 10.1152/jn.00120.2006 |
0.668 |
|
| 2005 |
Fehrenbacher JC, Burkey TH, Nicol GD, Vasko MR. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain. 113: 113-22. PMID 15621371 DOI: 10.1016/j.pain.2004.09.031 |
0.607 |
|
| 2003 |
Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain. 105: 133-41. PMID 14499429 DOI: 10.1016/S0304-3959(03)00173-8 |
0.645 |
|
| Show low-probability matches. |